1. Home
  2. OPRA vs DVAX Comparison

OPRA vs DVAX Comparison

Compare OPRA & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPRA
  • DVAX
  • Stock Information
  • Founded
  • OPRA 1996
  • DVAX 1996
  • Country
  • OPRA Norway
  • DVAX United States
  • Employees
  • OPRA N/A
  • DVAX N/A
  • Industry
  • OPRA Computer Software: Prepackaged Software
  • DVAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OPRA Technology
  • DVAX Health Care
  • Exchange
  • OPRA Nasdaq
  • DVAX Nasdaq
  • Market Cap
  • OPRA 1.6B
  • DVAX 1.5B
  • IPO Year
  • OPRA 2018
  • DVAX 2004
  • Fundamental
  • Price
  • OPRA $19.30
  • DVAX $12.36
  • Analyst Decision
  • OPRA Strong Buy
  • DVAX Buy
  • Analyst Count
  • OPRA 4
  • DVAX 2
  • Target Price
  • OPRA $24.75
  • DVAX $22.00
  • AVG Volume (30 Days)
  • OPRA 696.6K
  • DVAX 3.0M
  • Earning Date
  • OPRA 10-29-2024
  • DVAX 11-07-2024
  • Dividend Yield
  • OPRA 4.13%
  • DVAX N/A
  • EPS Growth
  • OPRA 142.24
  • DVAX N/A
  • EPS
  • OPRA 1.78
  • DVAX 0.15
  • Revenue
  • OPRA $447,818,000.00
  • DVAX $260,810,000.00
  • Revenue This Year
  • OPRA $21.42
  • DVAX $23.13
  • Revenue Next Year
  • OPRA $15.51
  • DVAX $19.60
  • P/E Ratio
  • OPRA $10.96
  • DVAX $81.69
  • Revenue Growth
  • OPRA 17.82
  • DVAX N/A
  • 52 Week Low
  • OPRA $10.11
  • DVAX $9.74
  • 52 Week High
  • OPRA $20.00
  • DVAX $15.01
  • Technical
  • Relative Strength Index (RSI)
  • OPRA 66.37
  • DVAX 54.02
  • Support Level
  • OPRA $17.77
  • DVAX $11.51
  • Resistance Level
  • OPRA $20.00
  • DVAX $13.74
  • Average True Range (ATR)
  • OPRA 0.75
  • DVAX 0.58
  • MACD
  • OPRA 0.05
  • DVAX -0.10
  • Stochastic Oscillator
  • OPRA 75.78
  • DVAX 35.71

About OPRA Opera Limited

Opera Ltd is a world-wide internet brand with a large, engaged and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. The newest addition of browsers is the beta release of a Web3-centric browser for PC and mobile which is tailored for crypto enthusiasts.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: